this post was submitted on 02 Jan 2024
1237 points (98.3% liked)

Technology

59657 readers
2661 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots


founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
[–] ricecake@sh.itjust.works 31 points 11 months ago (1 children)

You actually can. The simplest way is to literally just give the research away and charge a fair price for the medicine. That's allowed.

The slightly more capitalist way would be to sell the rights to the government to recoup costs.

The slightly less capitalist way is for the government to notify you that you don't own it anymore because of the public good.

This is also ignoring exactly how much the public already funds the basic research that goes into pharmaceuticals, which is quite a bit more than you might expect, so the argument of what's even "fair" is less clearly in favor of the company than you might expect.

[–] jj4211@lemmy.world -3 points 11 months ago (1 children)

There's a tricky balance.

For every endeavor that could recoup its costs in a fairly reasonable way, there are several other attempts that end in failure.

If you know that best case your project can be modestly better than break even, but it will most likely completely fail, would you invest in it?

I could respect an argument for outright socializing pharmaceutical efforts and rolling the needs into taxes and cutting out the capitalist angle entirely, but so long as you rely on capitalist funding model in any significant amount, then you have to allow for some incentive. When the research is pretty much fully funded by public funds, that funding should come with strings attached, but here it seems the lead up was largely in capitalist territory.